(Yicai Global) Oct. 20 -- Realcan Pharmaceutical Group’s stock price surged after the medical products distributor said it will help AstraZeneca sell its products in China.

Shares of Realcan [SHE: 002589] rose as much as 8 percent today before closing 5.7 percent higher at CNY5.92 (89 US cents).

Under an agreement signed yesterday, Shandong province-based Realcan will market AstraZeneca’s products to local hospitals in the eastern Chinese province and through its nationwide network, it said in a statement without disclosing any financial details.

AstraZeneca plans to make Realcan its preferred distributor in Shandong and other regions, including for new drugs.

Realcan will also help the global drugmaker extend its treatment solution application in Shandong and provide technical support such as medicine and medical apparatus to the program, the company said.

Editor: Peter Thomas